4-[4-(3-Hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1,4-dihydropyrrolo[3,4-d]pyrazol-5-yl]benzoic acid (BioDeep_00000177485)

   

human metabolite blood metabolite


代谢物信息卡片


4-(4-(3-Hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-5-yl)benzoic acid

化学式: C25H19N3O4 (425.13754940000007)
中文名称: 4-[4,6-二氢-4-(3-羟基苯基)-3-(4-甲基苯基)-6-氧代吡咯并[3,4-C]吡唑-5(1H)-基]苯甲酸
谱图信息: 最多检出来源 Homo sapiens(blood) 90%

分子结构信息

SMILES: CC1=CC=C(C=C1)C1=NNC2=C1C(N(C2=O)C1=CC=C(C=C1)C(O)=O)C1=CC(O)=CC=C1
InChI: InChI=1S/C25H19N3O4/c1-14-5-7-15(8-6-14)21-20-22(27-26-21)24(30)28(18-11-9-16(10-12-18)25(31)32)23(20)17-3-2-4-19(29)13-17/h2-13,23,29H,1H3,(H,26,27)(H,31,32)



数据库引用编号

5 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Rongxin Chen, Hailin Xu, Zebin Guo, Peng Zhang, Jianxia Chen, Zheng Chen. CID16020046, a GPR55 antagonist, attenuates sepsis‑induced acute kidney injury. Molecular medicine reports. 2022 May; 25(5):. doi: 10.3892/mmr.2022.12671. [PMID: 35244189]
  • Seung-Jin Lee, Dong-Soon Im. GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression. International journal of molecular sciences. 2021 Dec; 22(23):. doi: 10.3390/ijms222313084. [PMID: 34884889]
  • Saeromi Kang, Ae-Yeon Lee, So-Young Park, Kwang-Hyeon Liu, Dong-Soon Im. O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice. International journal of molecular sciences. 2021 Mar; 22(6):. doi: 10.3390/ijms22063091. [PMID: 33803038]
  • Xiao-Lei Zhou, Xin Guo, Yu-Pin Song, Chong-Yue Zhu, Wei Zou. The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling. Acta pharmacologica Sinica. 2018 Mar; 39(3):459-471. doi: 10.1038/aps.2017.157. [PMID: 29188802]
  • Andrew J Brown, Irene Castellano-Pellicena, Carl P Haslam, Paula L Nichols, Simon J Dowell. Structure-Activity Relationship of the GPR55 Antagonist, CID16020046. Pharmacology. 2018; 102(5-6):324-331. doi: 10.1159/000493490. [PMID: 30296786]
  • Joshua S Kaplan, Nephi Stella, William A Catterall, Ruth E Westenbroek. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proceedings of the National Academy of Sciences of the United States of America. 2017 10; 114(42):11229-11234. doi: 10.1073/pnas.1711351114. [PMID: 28973916]
  • Fabrizio Montecucco, Alexander I Bondarenko, Sébastien Lenglet, Fabienne Burger, Fabiana Piscitelli, Federico Carbone, Aline Roth, Luca Liberale, Franco Dallegri, Karim J Brandt, Rodrigo A Fraga-Silva, Nikolaos Stergiopulos, Vincenzo Di Marzo, François Mach. Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis. Thrombosis and haemostasis. 2016 Oct; 116(5):987-997. doi: 10.1160/th16-02-0139. [PMID: 27465665]
  • Julia Kargl, Andrew J Brown, Liisa Andersen, Georg Dorn, Rudolf Schicho, Maria Waldhoer, Akos Heinemann. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function. The Journal of pharmacology and experimental therapeutics. 2013 Jul; 346(1):54-66. doi: 10.1124/jpet.113.204180. [PMID: 23639801]